[{"id":"f774965e-3959-4583-9cda-e63bbe0eac7c","acronym":"COSTIC","url":"https://clinicaltrials.gov/study/NCT06118047","created_at":"2023-11-07T20:13:22.146Z","updated_at":"2024-07-02T16:35:30.205Z","phase":"Phase 2","brief_title":"Crisaborole Ointment for Skin Toxicity Induced by Cetuximab","source_id_and_acronym":"NCT06118047 - COSTIC","lead_sponsor":"Sun Yat-sen University","biomarkers":" EGFR","pipe":"","alterations":" ","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Erbitux (cetuximab)"],"overall_status":"Recruiting","enrollment":" Enrollment 33","initiation":"Initiation: 08/01/2023","start_date":" 08/01/2023","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2023-11-06"}]